cprx stock price forecast

The average CATALYST PHARMACEUTICALS stock price prediction forecasts a potential upside of 6179 from the current CPRX share price of 717. About the Catalyst Pharmaceuticals Inc.


Crypto Perx Price Prediction 2022 2025 2030 Cprx Price Forecast

The Catalyst Pharmaceuticals stock price fell by -462 on the last day Monday 6th Jun 2022 from 736 to 702During the day the stock fluctuated 701 from a day low at 692 to a day high of 741The price has been going up and down for this period and there has been a -057 loss for the last 2 weeks.

. September 2022 CPRX to USD predictions. Thinking about buying or selling stock in CPRX. Ad Build Your Portfolio Your Way.

The median estimate represents a 7045 increase from the last price of 704. A Maximum price of 00200 minimum price of 00154 for September 2022. CPRX stock quote history news and other vital information to help you with your stock trading and investing.

Get free stock tools free stock ratings free stock charts and calculate the value of stocks to buy. At the start of September 2022 the price will be around 00184 USD. Try It for Just 1.

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1500 and a low estimate of 900. On average analysts rate CPRX stock as a buy. Choose Investments Using 0 Online Stock and ETF Trades.

Stock news by MarketWatch. Analyst estimates including CPRX earnings per share estimates and analyst recommendations. As of 2022 June 03 Friday current price of CPRX stock is 7075 and our data indicates that the asset price has been in an uptrend for the past 1 year or since its inception.

Meanwhile note that the median CPRX forecast price target median being the middle where half of analysts had a higher CPRX forecast and half had a lower CPRX forecast which is a different metric than the average or mean was 120 as of 2022-05-30 while the highest CPRX forecast in the analyst group was 150 and the lowest CPRX forecast. See the latest Catalyst Pharm Inc CPRX stock analysis price forecast news and more. The average Catalyst Pharmaceuticals stock forecast 2030 represents a -5976 decrease from the last price of 719999980926514.

Catalyst Pharmaceuticals Inc. CPRX scored across 33 valuation financial forecast performance and dividend due diligence checks. Provides Revenue Guidance for the Year 2022.

Catalyst Pharmaceuticals stock price as been showing a rising tendency so we believe that similar market segments were very popular. The lowest target is 909 and the highest is 1575. For Catalyst Pharmaceuticals stock forecast for 2030 12 predictions are offered for each month of 2030 with average Catalyst Pharmaceuticals stock forecast of 29 a high forecast of 342 and a low forecast of 245.

According to 11 analysts the average rating for CPRX stock is Buy The 12-month stock price forecast is 1117 which is. CPRX on MSN Money. CPRX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

What is CPRXs Earnings Per Share EPS forecast for 2022-2024. CPRX Complete Catalyst Pharmaceuticals Inc. Stock Price Forecast The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1500 and a low estimate of 900.

According to 11 stock analysts the average 12-month stock price forecast for CPRX stock is 1183 which predicts an increase of 6073. In-depth view of key statistics and finances for CATALYST PHARMACEUTICALS INC. Find the latest Catalyst Pharmaceuticals Inc.

Price forecast at the end of August 2022 00182 change for August 2022 8. View real-time stock prices and stock quotes for a full financial overview. Catalyst Pharmaceuticals Inc.

Get free stock tools free stock ratings free stock charts and calculate the value of stocks to buy. Stock Price Forecast. Close price at the end of the last trading day Wednesday 1st Jun 2022 of the CPRX stock was 703.

This is 236 less than the trading day before Tuesday 31st May 2022. Continued to forecast full year 2022 total revenues to be in the range of between 195 million and 205 million representing a 38 - 45 increase in total revenues as compared to 2021. CATALYST PHARMACEUTICALS s market cap is calculated by multiplying CPRXs current stock price of 717 by CPRXs total outstanding shares of 102780151.

During the day the stock fluctuated 549 from a day low at 692 to a day high of 730. Upgrade to Premium to see how. Find the latest Catalyst Pharmaceuticals Inc.

The average price for the month of August 2022 is 00176.


Catalyst Pharmaceuticals Inc The Big Breakout Cprx Stock Forecast Cprx Stock Analysis Cprx In 2022 Stock Analysis Analysis Trend Analysis


India Cements And 20 Years Of Consolidation Long Term Chart Analysis Stock Analysis Financial Instrument Consolidation


Ing Tradingview


Catalyst Pharmaceuticals Inc Price Cprx Forecast With Price Charts


Catalyst Pharmaceuticals Has Potential To Push Higher If They Can Overcome Current Headwinds Nasdaq Cprx Seeking Alpha


What Does The Future Hold For Catalyst Pharmaceuticals Inc Nasdaq Cprx These Analysts Have Been Cutting Their Estimates


If You Had Bought Catalyst Pharmaceuticals Nasdaq Cprx Stock Five Years Ago You Could Pocket A 43 Gain Today


Neptune Tradingview


Ptn Stock Forecast 2025 Expert Analysis Coin Decimal


Catalyst Pharmaceuticals Stock Forecast Up To 7 873 Usd Cprx Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis


Catalyst Pharmaceuticals Cprx Q1 Earnings Miss Revenues Up Y Y Nasdaq


Catalyst Pharmaceutical Inc Share Price Com Stk Usd0 001


Is Cprx A Good Stock To Buy Now


Catalyst Pharmaceuticals Has Potential To Push Higher If They Can Overcome Current Headwinds Nasdaq Cprx Seeking Alpha


Crypto Perx Price Prediction Cprx Forecast 2023 2024 2025 2026 2027 2028


Bec Stock Price And Chart Set Bec Tradingview


Cprx Stock Forecast 2022 2025 Expert Analysis Coin Decimal


Catalyst S Cprx Stock Up On 2022 Guidance For Firdapse Nasdaq


Here S Why We Think Catalyst Pharmaceuticals Nasdaq Cprx Is Well Worth Watching Nasdaq

Iklan Atas Artikel

Iklan Tengah Artikel 1